{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:52:38Z","timestamp":1762264358687,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870172","81670365"],"award-info":[{"award-number":["81870172","81670365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.peptides.2020.170474","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:02:18Z","timestamp":1608768138000},"page":"170474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy"],"prefix":"10.1016","volume":"137","author":[{"given":"Pan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.peptides.2020.170474_bib0005","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/jcmm.13076","article-title":"CD38 promotes angiotensin II-induced cardiac hypertrophy","volume":"21","author":"Guan","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2020.170474_bib0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fphar.2018.00896","article-title":"Wogonin attenuates isoprenaline-induced myocardial hypertrophy in mice by suppressing the PI3K\/Akt pathway","volume":"9","author":"Qian","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.peptides.2020.170474_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.peptides.2020.170474_bib0020","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.peptides.2020.170474_bib0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10741-018-9708-x","article-title":"Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death\/degeneration","volume":"23","author":"Takemura","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.peptides.2020.170474_bib0035","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12576-017-0557-5","article-title":"Investigating beta-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways","volume":"68","author":"Khalilimeybodi","year":"2018","journal-title":"J. Physiol. Sci."},{"issue":"10","key":"10.1016\/j.peptides.2020.170474_bib0045","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2174\/1389450115666140902124230","article-title":"Beta-adrenergic over-stimulation and cardio-myocyte apoptosis: two receptors, one organelle, two fates?","volume":"15","author":"Branco","year":"2014","journal-title":"Curr. Drug Targets"},{"issue":"12","key":"10.1016\/j.peptides.2020.170474_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167090","article-title":"The role of reactive oxygen species in beta-adrenergic signaling in cardiomyocytes from mice with the metabolic syndrome","volume":"11","author":"Llano-Diez","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.peptides.2020.170474_bib0055","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","article-title":"Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction","volume":"96","author":"Hill","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.peptides.2020.170474_bib0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15376516.2012.666650","article-title":"Oxidative stress and cardiac hypertrophy: a review","volume":"22","author":"Maulik","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.peptides.2020.170474_bib0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2019.06.018","article-title":"2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation","volume":"168","author":"Morishige","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.peptides.2020.170474_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0075","doi-asserted-by":"crossref","first-page":"H358","DOI":"10.1152\/ajpheart.00704.2012","article-title":"Natriuretic peptides and cGMP signaling control of energy homeostasis","volume":"304","author":"Moro","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.peptides.2020.170474_bib0080","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0008-6363(02)00667-3","article-title":"Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP","volume":"57","author":"Rosenkranz","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0090","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1172\/JCI116800","article-title":"Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide","volume":"92","author":"Wei","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0095","doi-asserted-by":"crossref","first-page":"H281","DOI":"10.1152\/ajpheart.00666.2014","article-title":"Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms","volume":"308","author":"Shi","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.peptides.2020.170474_bib0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1582-4934.2012.01661.x","article-title":"Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia\/reperfusion injury: role of thioredoxin-interacting protein","volume":"17","author":"Su","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.peptides.2020.170474_bib0110","first-page":"1932","article-title":"Isosteviol prevents the development of isoprenalineinduced myocardial hypertrophy","volume":"44","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvv129","article-title":"Cardioprotection by H2S engages a cGMP-dependent protein kinase G\/phospholamban pathway","volume":"106","author":"Bibli","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0120","first-page":"549","article-title":"Swimming exercise inhibits myocardial ER stress in the hearts of aged mice by enhancing cGMP-PKG signaling","volume":"21","author":"Chang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"Suppl. 3","key":"10.1016\/j.peptides.2020.170474_bib0125","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-132738","article-title":"Apoptosis and oxidative stress in neurodegenerative diseases","volume":"42","author":"Radi","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.peptides.2020.170474_bib0130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"1-2","key":"10.1016\/j.peptides.2020.170474_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-013-1686-7","article-title":"Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol","volume":"381","author":"Lu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/advan.00177.2016","article-title":"The renal and cardiovascular effects of natriuretic peptides","volume":"41","author":"Wong","year":"2017","journal-title":"Adv. Physiol. Educ."},{"issue":"5198","key":"10.1016\/j.peptides.2020.170474_bib0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.7839143","article-title":"Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension","volume":"267","author":"John","year":"1995","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.HYP.16.3.301","article-title":"Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes","volume":"16","author":"Steinhelper","year":"1990","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0155","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.RES.74.4.747","article-title":"Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor","volume":"74","author":"Barbee","year":"1994","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0160","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0006-291X(89)80158-5","article-title":"Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor","volume":"160","author":"Abell","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.peptides.2020.170474_bib0165","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cellsig.2015.07.001","article-title":"Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2","volume":"27","author":"Somanna","year":"2015","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.peptides.2020.170474_bib0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI119883","article-title":"Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts","volume":"101","author":"Calderone","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI118092","article-title":"Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression","volume":"96","author":"Fujisaki","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.peptides.2020.170474_bib0180","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1097\/HJH.0000000000002570","article-title":"Cardiac morphological and functional changes induced by C-type natriuretic peptide are different in normotensive and spontaneously hypertensive rats","volume":"38","author":"Caniffi","year":"2020","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.peptides.2020.170474_bib0185","first-page":"515","article-title":"Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide","volume":"51","author":"Feng","year":"1999","journal-title":"Sheng Li Xue Bao"},{"issue":"10","key":"10.1016\/j.peptides.2020.170474_bib0190","first-page":"742","article-title":"Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes","volume":"34","author":"Chen","year":"2011","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"10.1016\/j.peptides.2020.170474_bib0195","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00395-019-0730-5","article-title":"Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2","volume":"114","author":"Aluja","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.peptides.2020.170474_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109372","article-title":"The inhibitory role of Chinese materia medica in cardiomyocyte apoptosis and underlying molecular mechanism","volume":"118","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1-2","key":"10.1016\/j.peptides.2020.170474_bib0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-1759(02)00070-4","article-title":"Regulation and measurement of oxidative stress in apoptosis","volume":"265","author":"Curtin","year":"2002","journal-title":"J. Immunol. Methods"},{"issue":"7","key":"10.1016\/j.peptides.2020.170474_bib0215","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00059-002-2430-3","article-title":"Oxidative stress and apoptosis in heart dysfunction","volume":"27","author":"Kumar","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.peptides.2020.170474_bib0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0378-4274(95)03474-9","article-title":"Signalling mechanisms and oxidative stress in apoptosis","volume":"82-83","author":"Slater","year":"1995","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.peptides.2020.170474_bib0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1871529X11313020010","article-title":"Oxidative stress and transforming growth factor-beta1-induced cardiac fibrosis","volume":"13","author":"Purnomo","year":"2013","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.peptides.2020.170474_bib0230","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-291X(63)90566-7","article-title":"Isolation of adenosine 3\u2019, 5\u2019-monophosphate and guanosine 3\u2019, 5\u2019-monophosphate from rat urine","volume":"11","author":"Ashman","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.peptides.2020.170474_bib0235","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tips.2011.02.019","article-title":"Phosphodiesterases and cardiac cGMP: evolving roles and controversies","volume":"32","author":"Zhang","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.peptides.2020.170474_bib0240","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1253\/circj.CJ-12-0664","article-title":"Cyclic GMP-dependent signaling in cardiac myocytes","volume":"76","author":"Takimoto","year":"2012","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.peptides.2020.170474_bib0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.peptides.2020.170474_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lfs.2004.11.026","article-title":"Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells","volume":"77","author":"Lu","year":"2005","journal-title":"Life Sci."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120302230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120302230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:48:08Z","timestamp":1762264088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120302230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":50,"alternative-id":["S0196978120302230"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170474","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170474"}}